GlassScriptPhysician profile
Christopher Edward Rickman
NPI 1386845782
$806.46
in general payments reported to CMS, 2019-2025
14 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.11 · 2020: $97.86 · 2021: $46.40 · 2022: $244 · 2023: $69.81 · 2024: $78.35 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.63 | 2019-2022 | |
| Daiichi Sankyo INC. | $184.91 | 2019-2024 | Injectafer |
| Hologic Sales and Service, LLC | $86.62 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $73.13 | 2022-2025 | |
| Coopersurgical, INC. | $55.88 | 2023-2024 | Fisherbrand Disposable Liquid Infant Heel Warmer, Paragard T 380a |
| Mayne Pharma Commercial LLC | $46.87 | 2022-2025 | |
| Organon LLC | $36.30 | 2022-2025 | Jada System |
| Astellas Pharma US INC | $25.69 | 2025 | Veozah |
| Amgen INC. | $25.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.26 | 2022 | |
| Avion Pharmaceuticals | $14.94 | 2021 | |
| Shield Therapeutics INC | $14.86 | 2023 | Accrufer |
| Millicent US INC | $13.53 | 2025 | Femring, Intrarosa |
| Novo Nordisk INC | $13.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.